INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $256,273 | +10.6% | 4,918 | +34.4% | 0.00% | – |
| Q2 2023 | $231,688 | +10.5% | 3,659 | -7.5% | 0.00% | – |
| Q4 2022 | $209,734 | -27.7% | 3,954 | -56.5% | 0.00% | – |
| Q4 2020 | $290,000 | -5.2% | 9,088 | -23.9% | 0.00% | -100.0% |
| Q2 2020 | $306,000 | +11.7% | 11,940 | -67.4% | 0.00% | 0.0% |
| Q3 2019 | $274,000 | -73.9% | 36,654 | -24.2% | 0.00% | -50.0% |
| Q3 2018 | $1,049,000 | +414.2% | 48,357 | +318.1% | 0.00% | – |
| Q2 2018 | $204,000 | -89.8% | 11,566 | -87.8% | 0.00% | -100.0% |
| Q1 2018 | $1,996,000 | +1132.1% | 94,808 | +783.1% | 0.00% | – |
| Q4 2016 | $162,000 | – | 10,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |